Detalles de la búsqueda
1.
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study.
Oncologist
; 24(9): 1153-1158, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833486
2.
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Lancet Oncol
; 14(11): 1121-1128, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24007746
3.
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
J Clin Oncol
; 42(12): 1344-1349, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38335467
4.
Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors.
Breast Cancer Res
; 14(1): R1, 2012 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-22225711
5.
Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer.
Breast Cancer Res Treat
; 130(3): 825-31, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21976055
6.
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Clin Cancer Res
; 15(4): 1452-9, 2009 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19228746
7.
Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study.
Breast Cancer Res Treat
; 118(1): 81-7, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19308727
8.
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
Breast Cancer Res Treat
; 116(3): 521-7, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19139988
9.
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.
NPJ Breast Cancer
; 5: 36, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31667338
10.
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
Clin Breast Cancer
; 8(2): 178-86, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18621615
11.
The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
Clin Breast Cancer
; 8(6): 527-32, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19073509
12.
Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
Am J Surg
; 216(4): 689-693, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30041733
13.
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
J Clin Oncol
; 35(23): 2647-2655, 2017 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28398846
14.
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
Clin Breast Cancer
; 16(6): 471-479.e1, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27569274
15.
Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors.
Nutrients
; 7(7): 5156-76, 2015 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-26132992
16.
Weight loss interventions for breast cancer survivors: impact of dietary pattern.
PLoS One
; 10(5): e0127366, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26010254
17.
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Clin Cancer Res
; 21(19): 4305-11, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26041745
18.
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
Pharmaceuticals (Basel)
; 8(1): 107-22, 2015 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25789420
19.
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.
Clin Breast Cancer
; 11(4): 211-20, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21723792
20.
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial.
Clin Breast Cancer
; 11(2): 82-92, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21569994